Publications by authors named "Jay Luther"

Claim this Profile
P
Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.
Wei Zhang, Soo Young Hwang, Jay Luther

Curr Gastroenterol Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.
Paul George, Chantelle Marshall, Wei Zhang, Russell Goodman, Michael Butler, Jay Luther

Hepatol Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal and Liver Adverse Effects of Alcohol Use Disorder Medications: A Pharmacovigilance Analysis.
Soo Young Hwang, Jay Luther, Wei Zhang

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.
Richard Parker, Guru Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Jay Luther

Am J Gastroenterol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.
Gene Y Im, Amon Asgharpour, Elizabeth S Aby, Jonathan G Stine, Jessica L Mellinger, Jay Luther

J Clin Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Is nesting addiction medicine and hepatology care in the outpatient setting worthwhile? A retrospective case series at a single tertiary center.
Rachael Mahle, Paige McLean Diaz, Chantelle Marshall, Russell P Goodman, Esperance Schaefer, Jay Luther

Hepatol Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD).
Wesley Dixon, Kathleen E Corey, Jay Luther, Russell P Goodman, Esperance A Schaefer

J Clin Exp Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis.
Moyinoluwa Taiwo, Emily Huang, Vai Pathak, Annette Bellar, Nicole Welch, Jay Luther

JCI Insight· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Include Inflammatory Bowel Disease as a Notifiable Disease?
Maneesh Dave, Jay Luther, Farren Briggs

Gastroenterology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stigmatizing Language for Alcohol Use Disorder and Liver Disease on Liver Transplant Center Websites.
Rachael Mahle, Adedayo Okanlawon, Jay Luther, Jeremy Louissaint, Wei Zhang

JAMA Netw Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients.
Jessica E S Shay, Augustin Vannier, Stephanie Tsai, Rachel Mahle, Paige McLean Diaz, Jay Luther

Alcohol Alcohol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder.
Vladislav Fomin, Chantelle Marshall, Stephanie Tsai, Russell Goodman, Esperance Schaefer, Jay Luther

Clin Gastroenterol Hepatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease.
Augustin G L Vannier, Eric M Przybyszewski, Jessica Shay, Suraj J Patel, Esperance Schaefer, Jay Luther

Clin Gastroenterol Hepatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
Paige McLean Diaz, Augustin Vannier, Amit D Joshi, Rachael E Mahle, Eric M Przybyszewski, Jay Luther

Clin Transl Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated hepatology and addiction care for inpatients with alcohol use disorder improves outcomes: a prospective study.
Rachael Mahle, Paige McLean Diaz, Chantelle Marshall, Russell P Goodman, Esperance Schaefer, Jay Luther

Hepatol Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
Surendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, Aparna Govindan, Lei Zhao, Jay Luther

Oncologist· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effects of COVID-19 Hospitalization on the Trajectory of Liver Disease Progression.
Dilara Hatipoğlu, Connor Mulligan, Jeffrey Wang, Juan Peticco, Reid Grinspoon, Jay Luther

Gastro Hep Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia.
Zain M Virk, Ellen Zhang, Josanna Rodriguez-Lopez, Alison Witkin, Alexandra K Wong, Jay Luther

J Thromb Haemost· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An additional patient with SMAD4-Juvenile Polyposis-Hereditary hemorrhagic telangiectasia and connective tissue abnormalities: SMAD4 loss-of-function and gain-of-function pathogenic variants result in contrasting phenotypes.
Gregory M Gheewalla, Jay Luther, Saumya Das, Jeffrey B Kreher, Eleanor R Scimone

Am J Med Genet A· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The circulating proteomic signature of alcohol-associated liver disease.
Jay Luther, Augustin Gl Vannier, Esperance A Schaefer, Russell P Goodman

JCI Insight· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.
Augustin G L Vannier, Jessica E S Shay, Vladislav Fomin, Suraj J Patel, Esperance Schaefer, Jay Luther

JAMA Netw Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of .
Suraj J Patel, Nan Liu, Sam Piaker, Anton Gulko, Maynara L Andrade, Jay Luther

Sci Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder.
Augustin G L Vannier, Vladislav Fomin, Raymond T Chung, Suraj J Patel, Esperance Schaefer, Jay Luther

Gastro Hep Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions.
Jay Luther, Lawrence S Friedman

Clin Liver Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.
Sophie C Cazanave, Andrew D Warren, Maciej Pacula, Fayçal Touti, Anna Zagorska, Jay Luther

Sci Transl Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis